Table 1 of Fan, Mol Vis 2005; 11:625-631.


Table 1. MYOC polymorphisms observed in this study

187 HTG patients had been previously reported [15] and from them R91X, E300K, and Y471C were each found in one patient. The numbers under "Genotype frequency" are the counts of homozygotes, heterozygotes, and wildtype.

                                  Allele frequency (percentage)            Genotype frequency
                                 ----------------------------------   -------------------------------
            Sequence    Codon       HTG          NTG       Control       HTG        NTG      Control
Location     change     change    (n=588)      (n=212)     (n=562)     (n=294)    (n=106)    (n=281)
--------   ----------   ------   ----------   ---------   ---------   ---------   --------   --------
Exon 1     c.34G>C      G12R       3  (0.5)    1  (0.5)    4  (0.7)   0/  3/291   0/ 1/105   0/ 4/277
Exon 1     c.49G>T      A17S       0  (0.0)    0  (0.0)    1  (0.2)   0/  0/294   0/ 0/106   0/ 1/280
Exon 1     c.57G>T      Q19H       2  (0.3)    0  (0.0)    0  (0.0)   0/  2/292   0/ 0/106   0/ 0/281
Exon 1     c.136C>T     R46X       6  (1.0)    2  (0.9)    7  (1.2)   0/  6/288   0/ 2/104   0/ 7/274
Exon 1     c.227G>A     R76K      38  (6.5)   16  (7.5)   51  (9.1)   0/ 38/256   0/16/ 90   1/49/231
Exon 1     c.271C>T     R91X       1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281
Exon 1     c.284T>C     L95P       0  (0.0)    0  (0.0)    1  (0.2)   0/  0/294   0/ 0/106   0/ 1/280
Exon 2     c.624C>G     D208E      2  (0.3)    0  (0.0)    2  (0.4)   0/  2/292   0/ 0/106   0/ 2/279
Exon 3     c.734G>A     C245Y      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281
Exon 3     c.898G>A,    E300K      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281
           c.900G>A
Exon 3     c.938C>T     S313F      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281
Exon 3     c.1058C>T    T353I      9  (1.5)    3  (1.4)    4  (0.7)   0/  9/285   0/ 3/103   0/ 4/277
Exon 3     c.1412A>G    Y471C      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281

Exon 1     c.369C>T     T123T      2  (0.3)    0  (0.0)    4  (0.7)   0/  2/292   0/ 0/106   0/ 4/277
Exon 1     c.384G>C     R128R      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281
Exon 1     c.402A>G     Q134Q      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281
Exon 3     c.780A>G     A260A      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281
Exon 3     c.864C>T     I288I      1  (0.2)    0  (0.0)    3  (0.5)   0/  1/293   0/ 0/106   0/ 3/278
Exon 3     c.1464C>T    A488A      1  (0.2)    0  (0.0)    0  (0.0)   0/  1/293   0/ 0/106   0/ 0/281

Promoter   -83G>A         -       37  (6.3)   17  (8.0)   50  (8.9)   0/ 37/257   0/17/ 89   1/48/232
Intron 2   IVS2+35A>G     -      119 (20.2)   55 (25.9)   91 (16.2)   9/101/184   7/41/ 58   3/85/193
3'UTR      1515+73G>C     -        5  (0.9)    0  (0.0)    6  (1.1)   0/  5/289   0/ 0/106   0/ 6/275

Fan, Mol Vis 2005; 11:625-631 <http://www.molvis.org/molvis/v11/a74/>
©2005 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535